Vedadots
Q65·GS Paper 1 · Prelims 2021

Development of Recombinant Vector Vaccines

S&TBiotechnology & GeneticsStatement-basedMediumCurrent-affairs-linked

Question

With reference to recent developments regarding 'Recombinant Vector Vaccines', consider the following statements:

  1. 1.

    Genetic engineering is applied in the development of these vaccines.

  2. 2.

    Bacteria and viruses are used as vectors.

Options

a

1 only

b

2 only

c

Both 1 and 2

Answer
d

Neither 1 nor 2

Explanation

Both statements are correct. Recombinant vector vaccines use genetic engineering to isolate the antigen gene of a targeted pathogen and insert it into a harmless vector's genome. Both modified viruses (such as Adenoviruses used in COVID-19 vaccines) and attenuated bacteria (such as Salmonella or BCG strains) serve as delivery vectors to trigger a protective immune response. > Recombinant vector vaccines apply genetic engineering to insert target antigens into live viral or bacterial vectors. Answer: (c).

Question details

Year

2021

Paper

GS Paper 1

Question

Q65

Subject

Science & Technology

Sub-topic

Biotechnology & Genetics

Type

Statement-based

Difficulty

Medium

Nature

Current-affairs-linked

Source hint

COVID-19 Vaccine platforms / NCERT Biology Cl.12

Same sub-topic — other years

Biotechnology & Genetics has appeared in multiple papers:

See all questions on Biotechnology & Genetics

Browse every tagged question across all years

Explore →